Published in Bioorg Med Chem Lett on September 06, 2008
Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation. J Biol Chem (2009) 0.97
Bioactive products formed in humans from fish oils. J Lipid Res (2015) 0.95
F3 -Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegans. Curr Protoc Toxicol (2014) 0.76
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI. Bioorg Med Chem Lett (2009) 0.76
Omega-3 fatty acid supplementation in cancer therapy : does eicosapentanoic acid influence the radiosensitivity of tumor cells? Strahlenther Onkol (2011) 0.75
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A (1990) 5.31
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med (2002) 2.08
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med (1998) 1.98
Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol (2002) 1.79
Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem (1999) 1.53
Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc Natl Acad Sci U S A (1999) 1.45
IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A (1998) 1.43
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem (2006) 1.25
Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. "Dioxetane" intermediate versus beta-fragmentation of peroxyl radicals. J Biol Chem (2003) 0.98
Total synthesis of 8,12-iso-iPF3alpha-VI, an EPA-derived isoprostane: stereoselective introduction of the fifth asymmetric center. J Org Chem (2006) 0.92
Oxidized derivatives of omega-3 fatty acids: identification of IPF3 alpha-VI in human urine. J Lipid Res (2006) 0.86
Analogs of leukotriene B4: effects of modification of the hydroxyl groups on leukocyte aggregation and binding to leukocyte leukotriene B4 receptors. Prostaglandins (1987) 0.82
Reductive Deprotection of Silyl Groups with Wilkinson's Catalyst/Catechol Borane. Tetrahedron Lett (2007) 0.82
A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron (2004) 5.71
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol (2011) 4.67
Role of prostacyclin in the cardiovascular response to thromboxane A2. Science (2002) 4.59
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest (2006) 4.50
COX-2-derived prostacyclin confers atheroprotection on female mice. Science (2004) 2.87
Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation (2003) 2.77
Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation (2012) 2.76
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation (2003) 2.69
Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol (2002) 2.58
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest (2003) 2.27
Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat Med (2012) 2.13
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem (2007) 2.10
Prostanoids in health and disease. J Lipid Res (2008) 2.06
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.97
COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol (2007) 1.77
Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. J Biol Chem (2003) 1.77
COX-2-dependent cardiac failure in Gh/tTG transgenic mice. Circ Res (2003) 1.72
Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med (2012) 1.71
12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol (2004) 1.71
Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation (2008) 1.62
Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Prog Lipid Res (2005) 1.57
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci U S A (2006) 1.52
Circadian clocks and vascular function. Circ Res (2010) 1.52
Parecoxib, valdecoxib, and cardiovascular risk. Circulation (2005) 1.51
Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation (2008) 1.50
Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmacol (2002) 1.49
Developmental expression of functional cyclooxygenases in zebrafish. Proc Natl Acad Sci U S A (2002) 1.48
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc Natl Acad Sci U S A (2009) 1.41
Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol (2006) 1.41
Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation (2005) 1.40
Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation (2005) 1.40
COX-2-derived prostacyclin modulates vascular remodeling. Circ Res (2005) 1.37
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J Am Coll Cardiol (2008) 1.36
EBP, a program for protein identification using multiple tandem mass spectrometry datasets. Mol Cell Proteomics (2006) 1.36
Aromatic amino acids required for pili conductivity and long-range extracellular electron transport in Geobacter sulfurreducens. MBio (2013) 1.34
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids (2004) 1.31
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2. Gastroenterology (2006) 1.27
Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol (2013) 1.27
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol (2012) 1.23
Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med (2012) 1.22
Peripheral circadian clocks in the vasculature. Arterioscler Thromb Vasc Biol (2007) 1.20
Training translators for smart drug discovery. Sci Transl Med (2010) 1.19
Recalibrating intellectual property rights to enhance translational research collaborations. Sci Transl Med (2012) 1.18
Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice. Nat Med (2005) 1.16
Prostaglandin E synthases in zebrafish. Arterioscler Thromb Vasc Biol (2004) 1.16
Synthesis of 15R-PGD2: a potential DP2 receptor agonist. Bioorg Med Chem Lett (2005) 1.12
Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nat Med (2006) 1.12
Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury. J Neurochem (2004) 1.10
Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am J Physiol Cell Physiol (2006) 1.10
5-Oxo-ETE and the OXE receptor. Prostaglandins Other Lipid Mediat (2009) 1.09
15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol (2002) 1.08
Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation. J Biol Chem (2007) 1.08
The role of clock genes in pharmacology. Annu Rev Pharmacol Toxicol (2010) 1.08
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. Am J Respir Cell Mol Biol (2005) 1.08
Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method. Methods Enzymol (2007) 1.07
Reduced nitric oxide causes age-associated impairment of circadian rhythmicity. Circ Res (2008) 1.06
Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells. J Biol Chem (2004) 1.05
Intelligence in childhood epilepsy syndromes. Epilepsy Res (2003) 1.05
The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat. J Immunol (2002) 1.05
Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality. J Biol Chem (2006) 1.04
Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation (2010) 1.04
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol (2014) 1.03
The neuropsychological and language profile of children with benign rolandic epilepsy. Epilepsia (2005) 1.02
Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury. Circulation (2011) 1.01
Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. J Biol Chem (2007) 1.01
Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44. J Invest Dermatol (2012) 1.01
Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J Biol Chem (2007) 1.01
Terms and conditions: semantic complexity and aspirin resistance. Circulation (2004) 1.01
Screening of PGPR from saline desert of Kutch: growth promotion in Arachis hypogea by Bacillus licheniformis A2. Microbiol Res (2013) 1.00
Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav (2003) 1.00
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci U S A (2009) 1.00
5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin. J Allergy Clin Immunol (2003) 0.99
Memory and phonological awareness in children with Benign Rolandic Epilepsy compared to a matched control group. Epilepsy Res (2007) 0.99
Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res (2008) 0.98
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. Proc Natl Acad Sci U S A (2012) 0.98
Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid. J Biol Chem (2007) 0.98